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Quality of Systematic Reviews of Treatment Studies in Neurogenic Communication Disorders 
 
Evidence based clinical practice involves the blending of clinical expertise, patient values, and 
current best research evidence (Sackett et al.,1996). Clinicians report that the greatest challenge 
in implementing evidence based practice is finding time to remain abreast of the current best 
clinical evidence (Mullen, 2005). Several efforts have been initiated to accumulate clinical 
evidence in the form of systematic reviews of the treatment literature, as in the ANCDS Practice 
Guidelines project, ASHA National Center for Evidenced-based Practice, and the Cochrane 
Database.  
 
Because of the importance of systematic reviews to evidence based practice, it is essential that 
reviews be conducted with rigorous methodologies to avoid bias in conclusions (Schlosser et al, 
2007). Several methods have been proposed to allow for the evaluation of the quality of 
systematic reviews (Dolloghan, 2007; Schlosser et al., 2007); as of yet there is no established 
standard for appraisal of reviews.  In general, a systematic review should include an established 
protocol to address a set of clinical questions. All sources should be identified  and selection 
criteria established. A procedure for summarizing the data and evaluating the quality of the 
studies also is necessary. Reviews that include meta-analysis should include a variety of statistic 
methods. Among the strongest appraisal criteria are those described by Auperin et al. (1997). 
The purpose of this paper is to report on our evaluation of systematic reviews that have been 
conducted for treatment studies in neurogenic communication disorders.    
 
Methodology: We identified 15 systematic reviews of behavioral treatment research in 
neurogenic communication disorders (aphasia n=6, apraxia of speech n=3, dysarthria n=6) 
through searches of databases (PubMed, ANCDS, Cochrane) and hand searches of several 
journals. Two reviewers independently rated each systematic review on a set of 27 criteria  
described by Auperin et al. (1997) and rated on a scale of 0 (not included), 1 (addressed 
partially), and 2 (addressed adequately), leading to a maximum score of 54. Criteria examined 
the identification of protocol and selection of trials for each review (6 items), description of the 
clinical trials (4 items), evaluation of study quality (3 items), description of data collection 
procedures (3 items), statistical analysis (8 items), and application of results (3 items). The raters 
trained on the use of the coding system with two of the 15 articles (Robey, 1998; Palmer & 
Enderby, 2007). A third examiner was consulted when a discrepancy in scoring was identified. 
Upon resolution of discrepancies for these two articles, all other articles were coded 
independently.  Coding agreement was at 97%.   
 
Results:  Quality scores for the 15 articles are shown in Table 1. Among the 6 aphasia articles (3 
systematic reviews and 3 meta-analyses), quality scores ranged from 8 (Holland et al., 1996) to 
42 (Greener et al., 1999), with a mean score of 25.5/54. Of the 6 dysarthria articles (all 6 
systematic reviews), quality scores ranged from 10 (Palmer & Enderby (2007) to 33 (Deane et 
al., 2001), with a mean score of 22.17/54. Among the 3 apraxia of speech articles (2 systematic 
reviews and 1 meta-analysis), scores ranged from 16 (Wambaugh & Doyle, 1994) to 47 West et 
al. (2008), with a mean score of 27.6/54.  
 
Several of the rating criteria were weighted in favor of statistical analyses that are typically seen 
in meta-analysis. Therefore we evaluated the studies on a sub-score for those criteria relevant to 
systematic reviews, leading to a maximum score of 38. The mean scores were: 20.50 aphasia; 
22.17 dysarthria, and 23.00 apraxia of speech. That is, apraxia of speech reviews tended to be of 
higher quality whether using the full 54 point score or the modified 38 point score, largely 
skewed by an excellent review by West et al. (2008). Aphasia systematic reviews tended to have 
lower scores overall. 
 
Table 2 displays the number of studies that ‘adequately addressed’ each of the 27 different 
criteria evaluated.  Only 8 criteria were met by a majority of the 15 reviews, largely focusing on 
the methods for identifying the studies and descriptions of the studies included in the reviews. 
Several of the criteria important for avoiding bias in the synthesis and conclusions of the reviews 
were lacking. Other weaknesses across reviews centered on lack of statistical analyses. 
  
Discussion:  Some strong reviews have been completed in treatment studies for neurogenic 
communication disorders, particularly those conducted under the auspices of the Cochrane 
Collaboration. Yet there is considerable room for improvement across reviews. Some lower 
scores were noted for studies conducted in the more distant past (Holland et al., 1996; 
Wambaugh & Doyle, 1994) when methods for the conduct of systematic reviews were not as 
well established. Clearly, methods employed in systematic reviews and meta-analyses have 
evolved over the past two decades leading to an overall improvement in the quality of reviews in 
recent years. Nevertheless, there is still room for improvement. This project demonstrated 
patterns of weakness across reviews, including the observation that meta-analytic methods are 
too rarely implemented. In both systematic reviews and meta-analyses, researchers need to 
improve their reporting of protocols, extraction procedures to avoid selection bias, and 
consideration of the economic impact of the treatment research findings.   
 
The importance of current best evidence in evidence-based practice continues to receive primary 
consideration in medical speech pathology circles. Therefore, efforts will continue in the 
completion of systematic reviews and meta-analyses for neurogenic communication disorders. 
Our study is meant to challenge those completing such work to use rigorous review methods 
such that clinicians have access to summaries of the best, non-biased clinical research evidence.      
Table 1: Quality scores in review articles. 
 
Article    Score  Modified Score 
    Max 54 Max 38 
Aphasia 
Holland et al., 1996  8  8 
Robey, 1998   30  22 
Greener et al., 1999  42  28 
Bhogal et al., 2003  28  20 
Turner & Whitworth, 2006 18  18 
Cherney et al., 2008  27  27 
 
Dysarthria 
Deane et al., 2001 (PKN) 30  30 
Deane et al., 2001 (placebo) 33  33 
Yorkston et al., 2001  19  19 
Yorkston et al., 2003  20  20 
Palmer & Enderby, 2007 10  10 
Yorkston et al., 2007  21  21 
 
Apraxia of Speech 
Wambaugh & Doyle, 1994 16  16 
Wambaugh et al., 2006 20  20 
West et al., 2008  47  33 
 
 
Table 2: Number of studies achieving an ‘adequately addressed’ score for each methodologic 
criterion.  
 
Criterion    Aphasia Dysarthria Apraxia of Speech Total 
     (n=6)  (n=6)  (n=3)   (n=15) 
Protocol    0  1  0   1 
Literature search   4  5  3   12 
List of trials analyzed   6  6  3   15 
Log of rejected trials   2  1  0   3 
Selection method   1  0  0   1 
Control of publication bias  3  2  1   6 
Description of patients  4  3  2   9 
Description of treatments  4  6  3   13 
Description of diagnoses  4  6  3   13 
Clinical combinabilitiy criteria 3  0  1   4 
Only randomized trials pooled 1  2  1   4 
Trial quality assessment  5  4  3   12 
Intention-to-treat analysis  1  1  1   3 
Data extraction method  2  0  1   3 
Inter-observer agreement  3  2  2   7 
Contact with trial investigators 1  2  1   4 
Statistical methods   3  0  1   4 
Statistical errors   0  0  0   0 
Confidence intervals   2  0  1   3 
Test of homogeneity   1  0  1   2 
End point quality   3  0  1   4 
Sensitivity analysis   1  0  1   2 
Subgroup analyses   2  0  1   3 
Indirect analyses   3  0  1   4 
Clinical impact   5  5  2   12 
Economic impact   0  2  0   2 
Specification of source of support 5  5  3   13 
